Is Roche Spending Too Much for Spark Therapeutics?
Spark Therapeutics shares more than doubled to start out the week after the company announced that it would be acquired by Swiss health care giant Roche, which is looking to add to its portfolio.
All Work
Chris Lange
What Ipsen Wants From Clementia Pharmaceuticals
Clementia Pharmaceuticals has entered into an agreement to be acquired by French pharmaceutical company Ipsen.
Home Depot, Nordstrom, Macy’s and More Major Retailers Reporting This Week
The first round of retail earnings has come and gone. Here, 24/7 Wall St. has reviewed Best Buy, Home Depot and some of the other key retailers reporting this coming week.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a positive day for the broad U.S. markets. Despite seeing some major stocks take a beating in this trading session, the broad markets pulled it out and posted a gain for the…
How Kraft Heinz Just Destroyed Shareholders (and Maybe Its Future)
Kraft Heinz felt the hurt on Friday after releasing earnings, announcing a probe by federal regulators and writing down a couple of its major brands. It was far and away the single worst trading…
Why Stamps.com Is Getting Halved
Stamps.com shares were absolutely destroyed after the firm reported its most recent quarterly results after the markets closed on Thursday.
Why This New Collaboration Is Incredible for Voyager Therapeutics
Voyager Therapeutics shares made an incredible gain on Friday after the firm announced a collaboration with pharma giant AbbVie.
Why More Investors Are Tuning In to Roku
Roku released better-than-expected fourth-quarter financial results after markets closed Thursday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a down day for the broad U.S. markets. We are now reaching the point in earnings season where more retailers will be reporting. Crude oil backed off for the first time this…
Why Tesla Is Getting Dragged by Consumer Reports
Tesla shares dipped on Thursday after a new report questioned the reliability of its Model 3. Consumer Reports claimed that it will no longer recommend Tesla’s Model 3 for a number of reasons.
What to Expect When Hewlett Packard Enterprise Reports After the Close
Hewlett Packard Enterprise is set to release its most recent quarterly results after the markets close on Thursday.
What to Watch For in Roku Earnings
Roku is scheduled to release its most recent quarterly results after the markets close on Thursday, and Wall Street expects very different numbers than a year ago.
Is Merck Overpaying for Immune Design?
Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some might call a ridiculous premium
Why Investors Aren’t Hungry for Domino’s After Earnings
Domino’s Pizza reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a relatively positive day for the broad U.S. markets. We are now reaching the point in earnings season where more retailers will be reporting. Walmart led the Dow to start the truncated…
What to Expect When Roku Reports on Thursday
Roku is scheduled to release its most recent quarterly results after the markets close on Thursday, and Wall Street expects very different numbers than a year ago.
Who’s to Blame for the US Opioid Epidemic
For more than half a decade, the United States has seen an incredible rise of an opioid epidemic within its borders. According to a recent study, drug makers and federal regulators are the ones…
Is Tesla in Trouble After Another Executive Departure?
With Valentine’s Day clearly in the rear view, one of the biggest breakups this week is coming from Tesla.
Why the Future Looks Bright for Kandi Tech
Kandi Technologies is officially throwing its hat in the electric vehicle ring after it received approval from the U.S. National Highway Traffic Safety Administration for two models.
How CVS Fell Short Despite Solid Q4 Results
CVS Health shares retreated after it reported mixed fourth-quarter financial results and lower guidance early Wednesday.